MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...
First study of its kind: No prior published research has examined neurocognitive changes after a full 30-session TMS course in patients with treatment-resistant depression. Processing speed improved ...
TMS uses electromagnetic induction to stimulate neurons, similar to how a wireless charger transfers energy. The FDA has cleared TMS for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder ...
Over 80% of participants experienced significant symptom improvement with a novel transcranial magnetic stimulation (TMS) protocol developed by Family Care Center. More than half of patients reached ...
BURLINGTON, Mass. and JERUSALEM, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, is proud to ...
SAN ANTONIO, May 27, 2026 /PRNewswire/ -- A peer-reviewed case study published in the journal Transcranial Magnetic Stimulation reports that an accelerated transcranial magnetic stimulation (aTMS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results